ArticleCancer research2011

Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers -- Letter.

Amaury G Dumont et al.PubMed ↗Publisher ↗

No numbers read from the abstract.